-
MannKind Corporation is a
biopharmaceutical company focusing on the discovery, development, and
commercialization of
therapeutic products for diseases...
- Afrezza, a
monomeric inhaled,
ultra rapid-acting
insulin developed by
Mannkind, was
approved by the FDA in 2014 and is the only
inhaled insulin commercialized...
- However,
other smaller pharmacutical companies also
produce insulin, such as
Mannkind (Afrezza),
Viatris (Semglee),
Lupin (Lupisulin),
Baxter (Myxredlin), Biocon...
-
Administration approved MannKind Corporation's
application for a
unique inhalable insulin (Afrezza) for the
treatment of diabetes.
Mannkind subsequently licensed...
-
Appointed to
MannKind Board of Directors". www.nasdaq.com. Nasdaq.
November 30, 2020.
Retrieved June 5, 2023. "Sabrina Kay
Appointed to
MannKind Board of...
- from
Navidea Biopharmaceuticals and an
inhalable insulin therapy from
MannKind Corporation while publicly short-selling both companies' stocks, the values...
-
Lundbeck Seattle (2004– )
Lupin Limited (1968– )
Mallinckrodt (1867– )
MannKind Corporation (1991– )
Mankind (1991– ) Mapp (2003– )
Martin Dow (1995– )...
-
Family Alfred Mann No businessman,
entrepreneur billionaire,
founder of
MannKind Corporation Frank Marino No
impersonator longest running, successful, nightly...
-
companies such as Eli
Lilly and Company, DEKA
Research & Development,
MannKind Corporation, and the
National Cancer Institute. On
January 7, 2022, a porcine...
- California. He
performs with the
Martan Mann Trio, the
Martan Mann &
Mannkind (contemporary jazz band) and has
performed with
George Young and Dmitri...
